Association between ulcerative colitis and multiple sclerosis

Internal Medicine Journal

Volumn 37, Issue 10, 2007, Pages 721-724

  Pokorny, C S ^a,b,e   Beran, R G ^a,b,c   Pokorny, M J ^d  

^a LIVERPOOL HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

^d UNIVERSITY OF WESTMINSTER   (United Kingdom)

^e NONE   (Australia)

Author keywords

Anti tumour necrosis factor; Crohn's disease; Multiple sclerosis; Ulcerative colitis

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ATENOLOL; BACLOFEN; BETA INTERFERON; DEXFENFLURAMINE; DIAZEPAM; ESOMEPRAZOLE; FLUINDOSTATIN; INTERFERON; MERCAPTOPURINE; MESALAZINE; METOPROLOL; PANTOPRAZOLE; PERINDOPRIL; PREDNISONE; SALAZOSULFAPYRIDINE; STEROID; VENLAFAXINE;

ADULT; AGED; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HUMAN; ILEOSTOMY; MALE; MEDICAL RECORD; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROCTOCOLECTOMY; ULCERATIVE COLITIS;

ADULT; AGED; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; RETROSPECTIVE STUDIES;

EID: 34748830279     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01452.x     Document Type: Article

References (22)

1. Talley NJ, Martin C, eds. Clinical Gastroenterology: A Practical Problem-Based Approach, 2nd edn. Marrickville : Elsevier 2006.
2. Barnett MH, Williams DB, Day S, Macaskill P, McLeod JG. Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle Australia. J Neurol Sci 2003 213 : 1 6.
3. Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The prevalence of extraintestinal diseases in inflammatory bowl disease: a population based study. Am J Gastroenterol 2001 96 : 1116 22.
4. Sadovnik AD, Dyment D, Ebers GC. Genetic epidemiology of multiple sclerosis. Epidemiol Rev 1997 19 : 99 106.
5. Broadley SA, Deans J, Sawcer SJ, Clayton D, Coupston DAS. Autoimmune disease in first degree relative of patients with multiple sclerosis. Brain 2000 123 : 1102 11.
6. Rang EH, Brooke BN, Taylor JH. Association of ulcerative colitis with multiple sclerosis. Lancet 1982 2 : 555.
7. Kimura K, Hunter SF, Thollander MS, Loftus EV, Melton LJ, O'Brien PC et al. Concurrence of inflammatory bowel disease and multiple sclerosis. Mayo Clin Proc 2000 75 : 802 6.
8. Sadovnick AD, Paty DW, Yannakoulias G. Concurrence of multiple sclerosis and inflammatory bowel disease. N Engl J Med 1989 321 : 762 3.
9. Gupta G, Gelfand JM, Lewis JD. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 2005 129 : 819 86.
10. Bernstein CN, Wajda A, Blanchard JF. The clustering of other inflammatory diseases in inflammatory bowel disease: a population based study. Gastroenterology 2005 129 : 827 36.
11. Boyko EJ, Perera DR, Koepsell TD, Keane EM, Inui TS. Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol 1988 23 : 1147 52.
12. Hernan MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H. Cigarette-smoking and the progression of multiple sclerosis. Brain 2005 128 : 1461 5.
13. Snapper SB, Podolsky DK. Epidemiology and genetic and environmental factors in inflammatory bowel disease. 2007 cited March 2007 Available from URL : http://www.uptodate.com.
14. Mayer JD. Geographical clues about multiple sclerosis. Ann Assoc Am Geogr 1981 71 : 28 39.
15. Fritzsche M. Geographical and seasonal correlation of multiple sclerosis to sporadic schizophrenia. Int J Health Geogr 2002 1 : 5.
16. Loftus EV. Inflammatory bowel disease extending its reach. Gastroenterology 2005 129 : 1117 20.
17. Constantinescu CS, Whiteley AM, Blumhardt LD. Long term azathioprine fails to suppress onset of multiple sclerosis. Mult Scler 2000 6 : 362 3.
18. Frohman EM, Stuve E, Havrdova E, Corboy J, Achiron A, Zivadinov R et al. Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations. Arch Neurol 2005 62 : 1519 30.
19. Musch E, Andus T, Kruis W, Raedler A, Spehlman M, Schreiber S et al. Interferon-Beta-1a for the treatment of steroid-refractory ulcerative colitis: a randomised, double-blind, placebo controlled trial. Clin Gastroenterol Hepatol 2005 3 : 581 6.
20. Sandborn WJ, Colombel JF, Enns R, Feagan BG, Hanauer SB, Lawrance IC et al. Natalizumab induction and maintenance therapy for Crohn's disease. N Engl J Med 2005 353 : 1912 25.
21. Feagan BG, Greenberg GR, Wild G, Fedorak P, Pare P, McDonald JW et al. Treatment of ulcerative colitis with a humanized antibody to alph4beta7 integrin. N Engl J Med 2005 352 : 2499 507.
22. Mohan N, Edwards ET, Cupps TR, Oliverio P, Sandberg G, Crayton H et al. Demyelination occurring during anti-tumor necrosis factor therapy for inflammatory bowel disease. Arthritis Rheum 2001 44 : 2862 9.